Matinas BioPharma Holdings Inc (NYSE American:MTNB)
| 1.56 Delayed Data As of 4:00pm ET |  -0.12 / -7.14%Today’s Change | 0.49 Today|||52-Week Range 2.22 | +14.71% Year-to-Date |
Latest MTNB News | Press Releases
No recent news for Matinas BioPharma Holdings Inc.
Today’s Trading
| Previous close | 1.68 |
| Today’s open | 1.60 |
| Day’s range | 1.51 - 1.66 |
| Volume | 4,786,055 |
| Average volume (3 months) | 3,503,786 |
| Market cap | $287.2M |
Data as of 4:00pm ET, 01/27/2021
Growth & Valuation
| Earnings growth (last year) | +17.54% |
| Earnings growth (this year) | +12.64% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -25.00% |
| P/E ratio | NM |
| Price/Sales | 3,669.81 |
| Price/Book | 8.08 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IPHAInnate Pharma SA | 0.00 | 0.00% |
| EIGREiger BioPharmaceuti... | -0.81 | -7.74% |
| MEIPMEI Pharma Inc | -0.05 | -1.65% |
| CNCEConcert Pharmaceutic... | -0.65 | -6.14% |
Data as of 3:59pm ET, 01/27/2021
Financials
| Next reporting date | April 6, 2021 |
| EPS forecast (this quarter) | -$0.03 |
| Annual revenue (last year) | $89.8K |
| Annual profit (last year) | -$17.4M |
| Net profit margin | -19,343.35% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Bedminster, New Jersey |
Forecasts
